A review of the use of natural compounds in the treatment of ulcerative colitis
Dr.Shabnam Bahrami1, Hadi Esmaeili Gouvarchin Ghaleh 2
1Applied Virology Research Center, Baqiyatallah University of Medical Science, Tehran, Iran.
2Applied Virology Research Center, Baqiyatallah University of Medical sciences, Tehran, Iran.
*Corresponding author
Dr. Shabnam Bahrami, Applied Virology Research Center, Baqiyatallah University of Medical sciences, Tehran, Iran.
Table 1: Persian and scientific name and family of anti diarrheal plants of Iran, their used parts, and the regions where they are used in treatment of colitis ulcerative.
- De Souza, H. S., & Fiocchi, C. (2016). Immunopathogenesis of IBD: current state of the art. Nature reviews Gastroenterology & hepatology, 13(1), 13-27.
- AHMADI NEJAD, S., ABBASNEJAD, M., DERAKHSHANFAR, A., ESMAILI MEHANI, S., & KOHPEYMA, H. (2014). THE EFFECT OF INTRACOLONIC MATRICARIA RECUTITA L. AQUEOUS EXTRACT ON ACETIC ACID–INDUCED ULCERATIVE COLITIS IN ADULT MALE RATS. GOVARESH JOURNAL, 19(1), -.
- Espaillat, M. P., Kew, R. R., & Obeid, L. M. (2017). Sphingolipids in neutrophil function and inflammatory responses: mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis. Advances in biological regulation, 63, 140-155.
- Feuerstein, J. D., & Cheifetz, A. S. (2014). Ulcerative colitis: epidemiology, diagnosis, and management. Paper presented at the Mayo Clinic Proceedings.
- Dulai, P. S., Jairath, V., Khanna, R., Ma, C., McCarrier, K. P., Martin, M. L., . . . Sandborn, W. J. (2020). Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther, 51(11), 1047-1066. doi:10.1111/apt.15726
- Murakami, T., Kamada, K., Mizushima, K., Higashimura, Y., Katada, K., Uchiyama, K., . . . Itoh, Y. (2017). Changes in intestinal motility and gut microbiota composition in a rat stress model. Digestion, 95(1), 55-60.
- El-Salhy, M. (2012). Irritable bowel syndrome: diagnosis and pathogenesis. World journal of gastroenterology: WJG, 18(37), 5151.
- Eaden, J., Abrams, K., Ekbom, A., Jackson, E., & Mayberry, J. (2000). Colorectal cancer prevention in ulcerative colitis: a case-control study. Alimentary pharmacology & therapeutics, 14(2), 145-153.
- Hugot, J.-P., Alberti, C., Berrebi, D., Bingen, E., & Cézard, J.-P. (2003). Crohn's disease: the cold chain hypothesis. The Lancet, 362(9400), 2012-2015.
- Greenstein, A., Sachar, D., Gibas, A., Schrag, D., Heimann, T., Janowitz, H., & Aufses Jr, A. (1985). Outcome of toxic dilatation in ulcerative and Crohn's colitis. Journal of clinical gastroenterology, 7(2), 137-143.
- Saxena, A., Kaur, K., Hegde, S., Kalekhan, F. M., Baliga, M. S., & Fayad, R. (2014). Dietary agents and phytochemicals in the prevention and treatment of experimental ulcerative colitis. Journal of traditional and complementary medicine, 4(4), 203-217.
- Tripathi, K., Dong, J., Mishkin, F., & Feuerstein, J. D. (2021). Patient preference and adherence to aminosalicylates for the treatment of ulcerative colitis. Clinical and experimental gastroenterology, 14, 343.
- Paridaens, K., Fullarton, J. R., & Travis, S. P. (2021). Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis. Current Medical Research and Opinion, 37(11), 1891-1900.
- Bashiri, H., & Bozorgomid, A. (2020). Protective Effect of Asacol in Combination with Pantoprazole in Ulcerative Colitis Patients Who Defecate Asacol Tablets Intactly: A Clinical Trial Study. Clinical and experimental gastroenterology, 13, 47.
- Sobecki, , Patel, K., Kahl, R., & Minaudo, M. (2020). Balsalazide-Induced Pneumonitis Causing Dyspnea in a Patient With Inflammatory Bowel Disease. ACG Case Reports Journal, 7(1).
- Date, A. A., Halpert, G., Babu, T., Ortiz, J., Kanvinde, P., Dimitrion, P., . . . Musmanno, O. (2018). Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease. Biomaterials, 185, 97-105.
- Banerjee, R., Ravikanth, V. V., Pal, P., Bale, G., Avanthi, U. S., Goren, I., . . . Reddy, D. N. (2020). NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine‐induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India. Alimentary pharmacology & therapeutics, 52(11-12), 1683-1694.
- Herfarth, H., Barnes, E. L., Valentine, J. F., Hanson, J., Higgins, P. D., Isaacs, K. L., . . . Ivanova, A. (2018). Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis. Gastroenterology, 155(4), 1098-1108. e10.99 .
- Melero, A., Draheim, C., Hansen, S., Giner, E., Carreras, J. J., Talens-Visconti, R., . . . Giner, R. (2017). Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model. European Journal of Pharmaceutics and Biopharmaceutics, 119, 361-371.
- Gisbert, J. P., & Chaparro, M. (2020). Predictors of primary response to biologic treatment [anti-TNF, vedolizumab, and ustekinumab] in patients with inflammatory bowel disease: from basic science to clinical practice. Journal of Crohn's and Colitis, 14(5),694-709.
- Comar, K. M., & Kirby, D. F. (2005). Herbal remedies in gastroenterology. Journal of Clinical Gastroenterology, 39(6), 457-468.
- Tillisch, K. (2007). Complementary and alternative medicine for gastrointestinal disorders. Clinical medicine, 7(3), 224.
- D’Inca, R., Garribba, A. T., Vettorato, M. G., Martin, A., Martines, D., Di Leo, V., ... & Sturniolo, G. C. (2007). Use of alternative and complementary therapies by inflammatory bowel disease patients in an Italian tertiary referral centre. Digestive and liver disease, 39(6), 524-529.
- Langmead, L., & Rampton, D. S. (2006). Complementary and alternative therapies for inflammatory bowel disease. Alimentary pharmacology & therapeutics, 23(3), 341-349.
- Langmead, L., Makins, R. J., & Rampton, D. S. (2004). Anti‐inflammatory effects of aloe vera gel in human colorectal mucosa in vitro.Alimentary pharmacology & therapeutics, 19(5), 521-527.
- Chen, Q., & Zhang, H. (1999). Clinical study on 118 cases of ulcerative colitis treated by integration of traditional Chinese and Western medicine. Journal of traditional Chinese medicine= Chung i tsa chih ying wen pan, 19(3), 163-165.
- Langmead, L., Chitnis, M., & Rampton, D. S. (2002). Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflammatory bowel diseases, 8(3), 174-179.
- Dahmen, U., Gu, Y. L., Dirsch, O., Fan, L. M., & Li, J. (2001). Boswellic acid, a potent antiinflammatory drug, inhibits rejection to the same extent as high dose steroids. In Transplantation proceedings(Vol. 33, No. 1-2, pp. 539-541).
- Frank, M. B., Yang, Q., Osban, J., Azzarello, J. T., Saban, M. R., Saban, R., ... & Lin, H. K. (2009). Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity. BMC Complementary and Alternative Medicine, 9(1), 1-11.
- Gupta, I., Parihar, A., Malhotra, P., Gupta, S., Lüdtke, R., Safayhi, H., & Ammon, H. P. (2001). Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta medica, 67(05), 391-395.
- Krieglstein, C. F., Anthoni, C., Rijcken, E. J., Laukötter, M., Spiegel, H. U., Boden, S. E., ... & Schürmann, G. (2001). Acetyl-11-keto-β-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. International journal of colorectal disease, 16(2), 88-95.
- Encyclopedia of Traditional Medicine (Medicinal Plants).
- Okonogi, S., Kaewpinta, A., Junmahasathien, T., & Yotsawimonwat, S. (2018). Effect of rice variety and modification on antioxidant and anti-inflammatory activities. Drug Discoveries & Therapeutics, 12(4), 206-213.
- Praengam, K., Sahasakul, Y., Kupradinun, P., Sakarin, S., Sanitchua, W., Rungsipipat, A., ... & Tuntipopipat, S. (2017). Brown rice and retrograded brown rice alleviate inflammatory response in dextran sulfate sodium (DSS)-induced colitis mice. Food & function, 8(12), 4630-4643.
- Jain, S. K. (1968). Medicinal plants(pp. 1-216). National Book Trust, India.
- Awaad, A. S., El-Meligy, R. M., & Soliman, G. A. (2013). Natural products in treatment of ulcerative colitis and peptic ulcer. Journal of Saudi chemical society, 17(1), 101-124.
- Tarvainen, M., Suomela, J. P., Kallio, H., & Yang, B. (2010). Triterpene acids in Plantago major: Identification, quantification and comparison of different extraction methods. Chromatographia, 71(3), 279-284.
- Atta, A. H., Nasr, S. M., & Mouneir, S. M. (2005). Antiulcerogenic effect of some plants extracts.
- Bahmani, M., Abaszadeh, A., Rafieian-Kopaei, M., & Naghdi, N. (2016). A review of the most important native medicinal plants of Iran effective on diarrhea. Journal of Chemical and Pharmaceutical Sciences, 9(3), 1294-1304.
- Santana, M. T., Cercato, L. M., Oliveira, J. P., & Camargo, E. A. (2017). Medicinal plants in the treatment of colitis: evidence from preclinical studies. Planta Medica, 83(07), 588-614.
- Kamali, M., Tavakoli, H., Khodadoost, M., Daghaghzadeh, H., Kamalinejad, M., Gachkar, L., ... & Adibi, P. (2015). Efficacy of the Punica granatum peels aqueous extract for symptom management in ulcerative colitis patients. A randomized, placebo-controlled, clinical trial. Complementary therapies in clinical practice, 21(3), 141-146.
- Kane, S. V., Cohen, R. D., Aikens, J. E., & Hanauer, S. B. (2001). Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. The American journal of gastroenterology, 96(10), 2929-2933.
- Červený, P., Bortlík, M., Kuběna, A., Vlček, J., Lakatos, P. L., & Lukáš, M. (2007). Nonadherence in inflammatory bowel disease: results of factor analysis. Inflammatory bowel diseases, 13(10), 1244-1249.
- Blackwood, A. D., Salter, J., Dettmar, P. W., & Chaplin, M. F. (2000). Dietary fibre, physicochemical properties and their relationship to health. The journal of the Royal Society for the Promotion of Health, 120(4), 242-247.